Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes

(2010) V. S. Raman et al.   DIABETES CARE

Effect of rimonabant, the cannabinoid CB1 receptor antagonist, on peripheral nerve in streptozotocin-induced diabetic rat

(2010) Wei Jing Liu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Time for Testing Incretin Therapies in Early Type 1 Diabetes?

(2010) Emanuele Bosi   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats

(2009) Heung Yong Jin et al.   ARCHIVES OF MEDICAL RESEARCH

New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)

(2009) Zhiwen Yu et al.   CELLULAR SIGNALLING

Effects of Exenatide Alone and in Combination With Daclizumab on  -Cell Function in Long-Standing Type 1 Diabetes

(2009) K. I. Rother et al.   DIABETES CARE

Delayed nerve repair increases number of caspase 3 stained Schwann cells

(2009) Harukazu Saito et al.   NEUROSCIENCE LETTERS

Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors

(2009) E.J. Verspohl   PHARMACOLOGY & THERAPEUTICS

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

(2009) Y. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epidermal nerve fiber quantification in the assessment of diabetic neuropathy

(2008) Kristina K. Beiswenger et al.   ACTA HISTOCHEMICA

Protection of exendin-4 analogue in early experimental diabetic retinopathy

(2008) Yu Zhang et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus

(2008) Prajakti A. Kothare et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The impact of bodyweight and body condition on behavioral testing for painful diabetic neuropathy in the streptozotocin rat model

(2008) Yves M.J.J. Hoybergs et al.   NEUROSCIENCE LETTERS